People

Gabriella Camboni

Biotechnology company builder, partner in Sofinnova’s Biovelocita strategy and CEO of BioClec, which develops microglia-targeted therapies for Alzheimer’s disease.

Roles

Sofinnova Partners

Partner, Sofinnova Partners - Biovelocita Strategy

Current
BioClec

Chief Executive Officer

Current